Perspective Therapeutics, Inc. (CATX)
USD 2.0
(4.17%)
USD 2.0
(4.17%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | 3.44 Million USD | 9.08% |
| 2021 | 3.16 Million USD | 5.05% |
| 2020 | 3.01 Million USD | 1.14% |
| 2019 | 2.97 Million USD | 70.84% |
| 2018 | 1.74 Million USD | -28.16% |
| 2017 | 2.42 Million USD | 45.47% |
| 2016 | 1.66 Million USD | -1.99% |
| 2015 | 1.7 Million USD | -23.42% |
| 2014 | 2.22 Million USD | -14.36% |
| 2013 | 2.59 Million USD | 53.54% |
| 2012 | 1.68 Million USD | 0.11% |
| 2011 | 1.68 Million USD | 17.47% |
| 2010 | 1.43 Million USD | -17.78% |
| 2009 | 1.74 Million USD | -1.78% |
| 2008 | 1.77 Million USD | -12.69% |
| 2007 | 2.03 Million USD | -39.37% |
| 2006 | 3.35 Million USD | 21.29% |
| 2005 | 2.77 Million USD | -87.03% |
| 2004 | 21.35 Million USD | 0.0% |
| 2002 | 565.12 Thousand USD | -47.86% |
| 2001 | 1.08 Million USD | 4.89% |
| 2000 | 1.03 Million USD | -19.47% |
| 1999 | 1.28 Million USD | 4.75% |
| 1998 | 1.22 Million USD | -62.99% |
| 1997 | 3.3 Million USD | -2.19% |
| 1996 | 3.38 Million USD | -7.14% |
| 1995 | 3.64 Million USD | 39.75% |
| 1994 | 2.6 Million USD | 1.01% |
| 1993 | 2.58 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q1 | 11.74 Million USD | 2.23% |
| 2022 FY | 3.44 Million USD | 9.08% |
| 2022 Q1 | 4.83 Million USD | 52.94% |
| 2022 Q2 | 3.26 Million USD | -32.4% |
| 2022 Q3 | 9.61 Million USD | 194.19% |
| 2022 Q4 | 11.49 Million USD | 19.5% |
| 2021 Q2 | 2.86 Million USD | -3.05% |
| 2021 Q4 | 3.16 Million USD | 8.59% |
| 2021 Q1 | 2.95 Million USD | -1.96% |
| 2021 FY | 3.16 Million USD | 5.05% |
| 2021 Q3 | 2.91 Million USD | 1.78% |
| 2020 Q4 | 3.01 Million USD | -5.41% |
| 2020 Q2 | 2.74 Million USD | -6.48% |
| 2020 Q1 | 2.93 Million USD | -1.55% |
| 2020 FY | 3.01 Million USD | 1.14% |
| 2020 Q3 | 3.18 Million USD | 16.13% |
| 2019 Q4 | 2.97 Million USD | -5.34% |
| 2019 Q1 | 3.16 Million USD | 81.92% |
| 2019 FY | 2.97 Million USD | 70.84% |
| 2019 Q2 | 2.79 Million USD | -11.9% |
| 2019 Q3 | 3.14 Million USD | 12.61% |
| 2018 Q3 | 1.96 Million USD | -12.38% |
| 2018 Q1 | 2.23 Million USD | -7.84% |
| 2018 Q2 | 2.24 Million USD | 0.49% |
| 2018 Q4 | 1.74 Million USD | -11.48% |
| 2018 FY | 1.74 Million USD | -28.16% |
| 2017 Q4 | 2.42 Million USD | 42.15% |
| 2017 FY | 2.42 Million USD | 45.47% |
| 2017 Q3 | 1.7 Million USD | 13.21% |
| 2017 Q2 | 1.5 Million USD | -7.83% |
| 2017 Q1 | 1.63 Million USD | -1.92% |
| 2016 FY | 1.66 Million USD | -1.99% |
| 2016 Q3 | 1.69 Million USD | 19.46% |
| 2016 Q1 | 1.71 Million USD | 0.66% |
| 2016 Q4 | 1.66 Million USD | -1.59% |
| 2016 Q2 | 1.41 Million USD | -17.17% |
| 2015 FY | 1.7 Million USD | -23.42% |
| 2015 Q3 | 2.27 Million USD | 3.56% |
| 2015 Q2 | 2.19 Million USD | 6.11% |
| 2015 Q4 | 1.7 Million USD | -25.11% |
| 2015 Q1 | 2.06 Million USD | -6.95% |
| 2014 Q4 | 2.22 Million USD | 11.74% |
| 2014 Q2 | 2.05 Million USD | -2.75% |
| 2014 FY | 2.22 Million USD | -14.36% |
| 2014 Q1 | 2.11 Million USD | -18.44% |
| 2014 Q3 | 1.98 Million USD | -3.38% |
| 2013 FY | 2.59 Million USD | 53.54% |
| 2013 Q1 | 1.92 Million USD | 13.68% |
| 2013 Q4 | 2.59 Million USD | 1.86% |
| 2013 Q3 | 2.54 Million USD | 49.87% |
| 2013 Q2 | 1.69 Million USD | -11.52% |
| 2012 Q1 | 1.5 Million USD | -10.86% |
| 2012 Q2 | 1.69 Million USD | 12.65% |
| 2012 Q3 | 1.55 Million USD | -8.23% |
| 2012 Q4 | 1.68 Million USD | 8.63% |
| 2012 FY | 1.68 Million USD | 0.11% |
| 2011 Q4 | 1.68 Million USD | 17.23% |
| 2011 FY | 1.68 Million USD | 17.47% |
| 2011 Q3 | 1.43 Million USD | -18.75% |
| 2011 Q2 | 1.77 Million USD | 11.02% |
| 2011 Q1 | 1.59 Million USD | 11.09% |
| 2010 Q2 | 2.9 Million USD | 71.62% |
| 2010 Q3 | 1.65 Million USD | -43.23% |
| 2010 Q4 | 1.43 Million USD | -12.96% |
| 2010 FY | 1.43 Million USD | -17.78% |
| 2010 Q1 | 1.69 Million USD | -3.04% |
| 2009 Q3 | 1.71 Million USD | 2.46% |
| 2009 Q4 | 1.74 Million USD | 1.78% |
| 2009 FY | 1.74 Million USD | -1.78% |
| 2009 Q2 | 1.67 Million USD | -9.11% |
| 2009 Q1 | 1.84 Million USD | 3.63% |
| 2008 Q1 | 2.05 Million USD | 1.08% |
| 2008 Q4 | 1.77 Million USD | -13.52% |
| 2008 FY | 1.77 Million USD | -12.69% |
| 2008 Q3 | 2.05 Million USD | 6.88% |
| 2008 Q2 | 1.92 Million USD | -6.55% |
| 2007 Q1 | 3.32 Million USD | -1.06% |
| 2007 Q4 | 2.03 Million USD | -12.51% |
| 2007 Q2 | 2.84 Million USD | -14.34% |
| 2007 Q3 | 2.32 Million USD | -18.23% |
| 2007 FY | 2.03 Million USD | -39.37% |
| 2006 FY | 3.35 Million USD | 21.29% |
| 2006 Q4 | 3.35 Million USD | 33.48% |
| 2006 Q2 | 3.01 Million USD | 5.09% |
| 2006 Q1 | 2.86 Million USD | 3.5% |
| 2006 Q3 | 2.51 Million USD | -16.46% |
| 2005 Q2 | 2.5 Million USD | -54.89% |
| 2005 FY | 2.77 Million USD | -87.03% |
| 2005 Q4 | 2.77 Million USD | 47.68% |
| 2005 Q3 | 1.87 Million USD | -25.19% |
| 2005 Q1 | 5.55 Million USD | 0.0% |
| 2004 Q1 | 392.63 Thousand USD | 1.07% |
| 2004 FY | 21.35 Million USD | 0.0% |
| 2004 Q3 | 94.17 Thousand USD | -76.23% |
| 2004 Q2 | 396.21 Thousand USD | 0.91% |
| 2003 Q2 | 568.06 Thousand USD | 0.52% |
| 2003 Q4 | 388.47 Thousand USD | -31.81% |
| 2003 Q3 | 569.65 Thousand USD | 0.28% |
| 2003 Q1 | 565.12 Thousand USD | 1.25% |
| 2002 Q2 | 1.09 Million USD | 0.7% |
| 2002 Q3 | 1.09 Million USD | 0.25% |
| 2002 Q1 | 1.08 Million USD | 0.37% |
| 2002 Q4 | 558.15 Thousand USD | -48.99% |
| 2002 FY | 565.12 Thousand USD | -47.86% |
| 2001 FY | 1.08 Million USD | 4.89% |
| 2001 Q1 | 1.03 Million USD | -22.63% |
| 2001 Q2 | 1.04 Million USD | 1.39% |
| 2001 Q3 | 1.06 Million USD | 1.69% |
| 2001 Q4 | 1.07 Million USD | 1.35% |
| 2000 Q3 | 1.31 Million USD | -5.7% |
| 2000 Q2 | 1.39 Million USD | 8.42% |
| 2000 Q1 | 1.28 Million USD | 1.54% |
| 2000 FY | 1.03 Million USD | -19.47% |
| 2000 Q4 | 1.33 Million USD | 1.81% |
| 1999 Q1 | 1.22 Million USD | 0.0% |
| 1999 Q2 | 1.23 Million USD | 1.06% |
| 1999 FY | 1.28 Million USD | 4.75% |
| 1999 Q3 | 1.25 Million USD | 1.04% |
| 1999 Q4 | 1.26 Million USD | 1.03% |
| 1998 FY | 1.22 Million USD | -62.99% |
| 1997 FY | 3.3 Million USD | -2.19% |
| 1996 FY | 3.38 Million USD | -7.14% |
| 1995 FY | 3.64 Million USD | 39.75% |
| 1994 FY | 2.6 Million USD | 1.01% |
| 1993 FY | 2.58 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Electromed, Inc. | 8.34 Million USD | 58.645% |
| Senseonics Holdings, Inc. | 64.76 Million USD | 94.675% |
| Catheter Precision, Inc. | 9.54 Million USD | 63.862% |
| Xtant Medical Holdings, Inc. | 41.26 Million USD | 91.641% |